Stem vs Widepoint
Stem reported revenue of $156 million in fiscal 2025, about the same as Widepoint's $150 million in fiscal 2025. Stem's revenue grew 8.1% in its latest year, and Widepoint's grew 5.6%. Stem had an operating margin of -35.6%, against -1.9% at Widepoint. Free cash flow was $7 million at Stem and $5 million at Widepoint.
Side by side
| Stem | Widepoint | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2025, Dec 31, 2025 |
| Revenue | $156M | $150M |
| Revenue growth | 8.1% | 5.6% |
| Revenue growth a year, last 5 years | 33.9% | −3.5% |
| Gross margin | 38.4% | 13.9% |
| Operating margin | −35.6% | −1.9% |
| Net margin | 88.2% | −1.8% |
| Free cash flow | $7M | $5M |
| Free cash flow margin | 4.4% | 3.6% |
| Return on capital | — | — |
| Net debt to EBITDA | — | — |
| Dividends and buybacks | $0M | $0M |
| Change in diluted share count | 5.2% | 3.8% |
| Last close | $0.73 | $6.20 |
| P/E at the last close | — | — |
| Insider trades, last 12 months | sold $160,319 | bought $24,880, sold $7.3 million |
| Piotroski F-score | 6 of 9 | — |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
StemWidepoint
Operating margin
Percent of revenue
StemWidepoint
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
StemWidepoint